These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 34370466)

  • 1. Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A.
    Jana AK; Greenwood AB; Hansmann UHE
    J Phys Chem B; 2021 Aug; 125(32):9155-9167. PubMed ID: 34370466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of a SARS-COV-2 protein enhances Amyloid Formation of Serum Amyloid A.
    Jana AK; Greenwood AB; Hansmann UHE
    bioRxiv; 2021 Jul; ():. PubMed ID: 34031653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.
    Jana AK; Lander CW; Chesney AD; Hansmann UHE
    J Phys Chem B; 2022 May; 126(20):3648-3658. PubMed ID: 35580331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an amyloidogenic SARS-COV-2 protein fragment on α-synuclein monomers and fibrils.
    Jana AK; Lander CW; Chesney AD; Hansmann UHE
    bioRxiv; 2022 Feb; ():. PubMed ID: 35233574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Human Serum Amyloid A Fibrils.
    Wang W; Hansmann UHE
    J Phys Chem B; 2020 Nov; 124(47):10708-10717. PubMed ID: 33197318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage, Downregulation, and Aggregation of Serum Amyloid A.
    Wang W; Khatua P; Hansmann UHE
    J Phys Chem B; 2020 Feb; 124(6):1009-1019. PubMed ID: 31955564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
    Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
    Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A.
    Lin X; Watanabe K; Kuragano M; Tokuraku K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for reactive amyloidosis.
    Gruys E; Snel FW
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats.
    Tei M; Uchida K; Chambers JK; Watanabe KI; Tamamoto T; Ohno K; Nakayama H
    J Vet Med Sci; 2018 Feb; 80(1):164-172. PubMed ID: 29199213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
    Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic production of acute phase serum amyloid A.
    Upragarin N; Landman WJ; Gaastra W; Gruys E
    Histol Histopathol; 2005 Oct; 20(4):1295-307. PubMed ID: 16136510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AA amyloidosis: pathogenesis and targeted therapy.
    Westermark GT; Fändrich M; Westermark P
    Annu Rev Pathol; 2015; 10():321-44. PubMed ID: 25387054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis.
    De Beer FC; Mallya RK; Fagan EA; Lanham JG; Hughes GR; Pepys MB
    Lancet; 1982 Jul; 2(8292):231-4. PubMed ID: 6124669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A.
    Colón W; Aguilera JJ; Srinivasan S
    Adv Exp Med Biol; 2015; 855():117-34. PubMed ID: 26149928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid environment on amyloid fibril formation of human serum amyloid A.
    Tanaka M; Nishimura A; Takeshita H; Takase H; Yamada T; Mukai T
    Chem Phys Lipids; 2017 Jan; 202():6-12. PubMed ID: 27865770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
    Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
    Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
    de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
    J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.